Pathology of hepatocellular carcinoma and its precursors using proton magnetic resonance spectroscopy and a statistical classification strategy

被引:46
作者
Soper, R
Himmelreich, U
Painter, D
Somorjai, RL
Lean, CL
Dolenko, B
Mountford, CE
Russell, P
机构
[1] Univ Sydney, Inst Magnet Resonance Res, Sydney, NSW 2006, Australia
[2] Univ Sydney, Dept Magnet Resonance Med, Sydney, NSW 2006, Australia
[3] Royal Prince Alfred Hosp, Dept Anat Pathol, Sydney, NSW, Australia
[4] Natl Res Council Canada, Inst Biodiagnost, Winnipeg, MB R3B 1Y6, Canada
关键词
hepatocellular disease pathology; magnetic resonance spectroscopy; cirrhosis; cancer; statistical analysis;
D O I
10.1080/0031302021000009324
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Aim: Apply the statistical classification strategy (SCS) to magnetic resonance spectroscopy (MRS) data from liver biopsies and test its potential to discriminate between normal liver, cirrhotic nodules and nodules of hepatocellular carcinoma with a high degree of accuracy. Methods: Liver tissue specimens from 54 patients undergoing either partial (hemi) or total hepatectomy were analysed by one-dimensional proton MRS at 8.5 Tesla. Histologically, these specimens were confirmed as normal (n = 31), cirrhotic (n = 59), and hepatocellular carcinoma (HCC, n = 32). Diagnostic correlation was performed between the MR spectra and histopathology. An SCS was applied consisting of pre-processing MR magnitude spectra to identify spectral regions of maximal discriminatory value, and cross-validated linear discriminant analysis. Results: SCS applied to MRS data distinguished normal liver tissue from HCC with an accuracy of 100%. Normal liver tissue was distinguished from cirrhotic liver with an accuracy of 92% and cirrhotic liver was distinguished from HCC with an accuracy of 98%. Conclusions: SCS applied to proton MRS of liver biopsies provides a robust method to distinguish, with a high degree of accuracy, HCC from both cirrhotic and normal liver.
引用
收藏
页码:417 / 422
页数:6
相关论文
共 32 条
[1]  
BARRY P, 1998, OESOPHAGOGASTRIC JUN, P1122
[2]   LIVER-CELL DYSPLASIA IS A MAJOR RISK FACTOR FOR HEPATOCELLULAR-CARCINOMA IN CIRRHOSIS - A PROSPECTIVE-STUDY [J].
BORZIO, M ;
BRUNO, S ;
RONCALLI, M ;
MELS, GC ;
RAMELLA, G ;
BORZIO, F ;
LEANDRO, G ;
SERVIDA, E ;
PODDA, M .
GASTROENTEROLOGY, 1995, 108 (03) :812-817
[3]  
Bubb WA, 1999, MAGN RESON MED, V42, P442, DOI 10.1002/(SICI)1522-2594(199909)42:3&lt
[4]  
442::AID-MRM6&gt
[5]  
3.0.CO
[6]  
2-Q
[7]  
Duvoux C, 1998, ANN CHIR, V52, P511
[8]  
Efron B., 1993, MONOGR STAT APPL PRO, V57
[9]  
Hagberg G, 1998, NMR BIOMED, V11, P148, DOI 10.1002/(SICI)1099-1492(199806/08)11:4/5<148::AID-NBM511>3.0.CO
[10]  
2-4